Samples for study ST002125
Species: Mus musculus (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | Source_Name[gating] | Treatment | Batch | Note | Sample_Data:RAW_FILE_NAME |
|---|---|---|---|---|---|---|---|
| SA204320 | - | BM_supernatant_5FU_1 | Bone marrow supernatant | 5 FU 2 weeks | 1c | Unlabeled AAs were used for total AA (FigS2.D) | bms-fu-1.cdf |
| SA204321 | - | BM_supernatant_5FU_2 | Bone marrow supernatant | 5 FU 2 weeks | 1c | Unlabeled AAs were used for total AA (FigS2.D) | bms-fu-2.cdf |
| SA204322 | - | BM_supernatant_5FU_3 | Bone marrow supernatant | 5 FU 2 weeks | 1c | Unlabeled AAs were used for total AA (FigS2.D) | bms-fu-3.cdf |
| SA204323 | - | BM_supernatant_Ctrl_1 | Bone marrow supernatant | HSC Basal | 1c | Unlabeled AAs were used for total AA (FigS2.D) | bms-ct-1.cdf |
| SA204324 | - | BM_supernatant_Ctrl_2 | Bone marrow supernatant | HSC Basal | 1c | Unlabeled AAs were used for total AA (FigS2.D) | bms-ct-2.cdf |
| SA204325 | - | BM_supernatant_Ctrl_3 | Bone marrow supernatant | HSC Basal | 1c | Unlabeled AAs were used for total AA (FigS2.D) | bms-ct-3.cdf |
| SA204326 | - | HSC_5FU_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J). | hsc-fu-1.cdf |
| SA204328 | - | HSC_5FU_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J). | hsc-fu-2.cdf |
| SA204327 | - | HSC_5FU_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J). | hsc-fu-3.cdf |
| SA204331 | - | HSC_5FU_0h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-0h-1.cdf |
| SA204330 | - | HSC_5FU_0h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-0h-2.cdf |
| SA204329 | - | HSC_5FU_0h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-0h-3.cdf |
| SA204333 | - | HSC_5FU_12h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-12h-1.cdf |
| SA204334 | - | HSC_5FU_12h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-12h-2.cdf |
| SA204332 | - | HSC_5FU_12h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-12h-3.cdf |
| SA204335 | - | HSC_5FU_6h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-6h-1.cdf |
| SA204337 | - | HSC_5FU_6h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-6h-2.cdf |
| SA204336 | - | HSC_5FU_6h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-fu-6h-3.cdf |
| SA204340 | - | HSC_Cultured_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C) and TCA substrate levels (Fig2.K). | hsc-cultured-1.cdf |
| SA204339 | - | HSC_Cultured_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C) and TCA substrate levels (Fig2.K). | hsc-cultured-2.cdf |
| SA204338 | - | HSC_Cultured_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C) and TCA substrate levels (Fig2.K). | hsc-cultured-3.cdf |
| SA204342 | - | HSC_Cultured_0h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-0h-1.cdf |
| SA204343 | - | HSC_Cultured_0h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-0h-2.cdf |
| SA204344 | - | HSC_Cultured_0h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-0h-3.cdf |
| SA204341 | - | HSC_Cultured_6h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-6h-1.cdf |
| SA204347 | - | HSC_Cultured_12h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-12h-1.cdf |
| SA204346 | - | HSC_Cultured_12h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-12h-2.cdf |
| SA204345 | - | HSC_Cultured_12h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-12h-3.cdf |
| SA204348 | - | HSC_Cultured_6h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-6h-2.cdf |
| SA204349 | - | HSC_Cultured_6h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D). | hsc-cultured-6h-3.cdf |
| SA204355 | - | HSC_Ctrl_0h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-0h-1.cdf |
| SA204353 | - | HSC_Ctrl_0h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-0h-2.cdf |
| SA204354 | - | HSC_Ctrl_0h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-0h-3.cdf |
| SA204358 | - | HSC_Ctrl_12h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-12h-1.cdf |
| SA204357 | - | HSC_Ctrl_12h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-12h-2.cdf |
| SA204356 | - | HSC_Ctrl_12h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-12h-3.cdf |
| SA204359 | - | HSC_Ctrl_6h_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-6h-1.cdf |
| SA204360 | - | HSC_Ctrl_6h_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-6h-2.cdf |
| SA204361 | - | HSC_Ctrl_6h_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h | 1b | [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D). | hsc-ct-6h-3.cdf |
| SA204351 | - | HSC_Ctrl_1 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J). | hsc-ct-1.cdf |
| SA204352 | - | HSC_Ctrl_2 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J). | hsc-ct-2.cdf |
| SA204350 | - | HSC_Ctrl_3 | Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) | HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h | 1c | [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J). | hsc-ct-3.cdf |
